Researchers at the Wyss Institute for Biologically Inspired Engineering at Harvard University have developed a novel biomimetic strategy that delivers nanotherapeutics directly to obstructed blood vessels, dissolving blood clots before they cause serious damage or death (with video).

Margaret Rosenfeld, MD, MPH, from Seattle Children's Hospital, provides insight into her study on hypertonic saline in children with cystic fibrosis.

Three recent animal studies suggest new ways of enhancing the immune system's ability to resist influenza.